Updates are available Correction dated 2022-04-26
Click to view Correction: https://0-doi-org.brum.beds.ac.uk/10.1186/s12876-021-01992-2
-
Authors
Bayoumy, Ahmed B. http://orcid.org/0000-0002-5302-9312
van Liere, Elsa L. S. A.
Simsek, Melek
Warner, Ben
Loganayagam, Aathavan
Sanderson, Jeremy D.
Anderson, Simon
Nolan, Jonathan
de Boer, Nanne K.
Mulder, Chris J. J.
Ansari, Azhar
- License Information
-
More Information
Article History
Received: 6 March 2020
Accepted: 3 September 2020
First Online: 11 September 2020
Change Date: 26 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://0-doi-org.brum.beds.ac.uk/10.1186/s12876-021-01992-2
Ethics approval and consent to participate
: According to the guidelines of the UK Health Research Authority, as the data were collected as part of routine clinical care and were evaluated retrospectively, the study was considered a review of clinical practice and ethical approval was not required [CitationRef removed]. This study was conducted in accordance with the Declaration of Helsinki [CitationRef removed].
: Not Applicable.
: AB Bayoumy and ELSA van Liere received travel grants from HLW Pharma. A Ansari has nothing to declare. M Simsek has received an unrestricted research grant from TEVA Pharma.CJJ Mulder has served as consultant and principal investigator for TEVA Pharma B.V. He has served as consultant and principal investigator for Takeda and TEVA Pharma B.V. He has received a (unrestricted) research grant from Dr. Falk and Takeda.NKH de Boer has served as a speaker for AbbVie and MSD and as a consultant and principal investigator for TEVA Pharma BV and Takeda. He has received unrestricted research grants from Dr. Falk, TEVA Pharma BV and Takeda.
